MediPoint: Percutaneous Coronary Interventions - Global Analysis and Market Forecasts Summary Coronary stents, which include bare metal stents, drug-eluting stents (DESes), covered stents, and bioabsorbable stents (BASes) De novo stenosis, acute myocardial infarction (AMI), bifurcation lesions, small vessel disease (SVD), saphenous vein grafts (SVGs), left main coronary artery disease (LMCAD), and chronic total occlusions (CTOs) In the US and 5EU, coronary stents market value is expected to decline slowly, whereas it is expected to demonstrate steady growth in the APAC and South American regions Newer technologies, such as BASes and the third generation of DESes aim to address unmet needs of complex lesions and challenging populations The development and commercialization of the next generation of DESes with innovative platforms indicates the continued value of DESes in the coronary market The coronary stents market is largely dominated by a few key players, including Abbott Vascular, Medtronic, and Boston Scientific Other key players include B. Braun, Biosensors International, Biotronik, and Terumo as they develop innovative coronary stent platforms. Highlights Key Questions Answered - What is the current and future percutaneous coronary interventions market outlook in the developed and emerging markets? What trends are affecting the global market? - Which are the key, high growth markets that device manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment? - What are the unmet needs with the current generation of devices? How will emerging technologies such as bioabsorbable stents and drug-eluting stents fulfill these unmet needs? - What is the physician perception of these new technologies? Which indications have been treated most successfully using minimally invasive treatments? - What are the challenges and complications that have hindered widespread adoption? - With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the global percutaneous coronary interventions market? Key Findings - Growth in the percutaneous coronary interventions market will be driven primarily by rising procedure volumes, the increasing global prevalence of coronary artery disease, and as rising rates of diabetes in particular. - The introduction of Bioabsorbable stents (BASes) can reduce or even eliminate the prolonged use of DAPT; as long-term clinical efficacy data become available, clinicians will prefer to use BASes over drug-eluting stents (DESes). - Bioabsorbable stents (BASes) are also expected to see fast adoption as they are introduced across major markets, as they have the potential to significantly reduce restenosis rates and allow for vessel remodeling. - The current key players will need to retain and acquire market share by improving the clinical performance of their existing products. Scope - Overview of percutaneous coronary interventions, including reimbursement trends and M&A analysis - Annualized total market revenue by type of device, procedure trends, and market outlooks by country through 2022. - Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies on the market. - Pipeline analysis: Comprehensive data split across different stages of development and analysis of emerging trends in design. - Analysis of the current and future market competition in the global percutaneous coronary interventions market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications. Reasons To Buy - The report will enable you to - - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global percutaneous coronary interventions market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global percutaneous coronary interventions market in the future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Track device sales in the global and country-specific peripheral vascular interventions market from 2012-2022. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Table of Contents
1 Table of Contents 5 1.1 List of Tables 8 1.2 List of Figures 10 2 Introduction 11 2.1 Catalyst 11 2.2 Related Reports 12 3 Market Access 13 3.1 Reimbursement Trends 13 3.1.1 North America 13 3.1.2 Europe 16 3.1.3 Asia-Pacific 17 3.1.4 South America 20 3.1.5 Middle East and Africa 21 3.2 Mergers and Acquisitions/Key Partnerships 23 4 Unmet Needs and Market Opportunity Analysis 24 4.1 Improving Clinical Outcomes in Complex Coronary Indications 24 4.1.1 Bifurcation Lesions 25 4.1.2 Chronic Total Occlusions 26 4.1.3 Heavily Calcified Lesions 27 4.1.4 Unprotected Left Main Coronary Artery Lesions 27 4.1.5 Acute Myocardial Infarction 28 4.1.6 Saphenous Vein Grafts 28 4.1.7 Small Vessel Lesions 29 4.2 Minimizing Late Stent Thrombosis Incidence 29 4.3 Procedure Optimization 29 4.4 Reducing Repeat Revascularization Rates 30 5 Competitive Assessment 32 5.1 Market Share Analysis 32 5.2 Key Companies and Product Profiles 34 5.2.1 Abbott Vascular 34 5.2.2 B. Braun 37 5.2.3 Biosensors International 41 5.2.4 Biotronik 45 5.2.5 Boston Scientific 49 5.2.6 Medtronic 53 5.2.7 Terumo 56 5.2.8 Other Players 58 5.3 Pipeline Products Assessment 61 5.4 Clinical Trials Assessment 64 6 Market Outlook 65 6.1 Procedure Trends 65 6.2 Global Market Drivers and Barriers 66 6.2.1 Driver: Rising Disease Prevalence 66 6.2.2 Driver: Launch of Bioabsorbable Stents on a Global Scale 67 6.2.3 Driver: Reducing Need for Antiplatelet Therapy 67 6.2.4 Barrier: Risk of Perioperative Adverse Cardiac Events Post-Stenting 68 6.2.5 Barrier: Post-ProceduraI Complications of Drug-Eluting Stenting 68 6.2.6 Barrier: Concerns Regarding Overstenting 69 6.3 Market Outlooks by Segment 70 6.3.1 Coronary Stents 70 6.3.2 Percutaneous Transluminal Coronary Angioplasty Balloons 72 6.3.3 Percutaneous Transluminal Angioplasty Drug-Eluting Balloons 74 6.4 Market Outlooks by Geography 74 6.4.1 Global Overview 74 6.4.2 North America 76 6.4.3 Europe 77 6.4.4 Asia-Pacific 78 6.4.5 South America 80 6.4.6 Middle East and Africa 81 7 Appendix 82 7.1 Bibliography 82 7.2 Abbreviations 92 7.3 Methodology 95 7.3.1 Overview 95 7.3.2 Coverage 95 7.3.3 Secondary Research 95 7.4 Forecasting Methodology 96 7.5 Primary Research Summary 96 7.6 About the Authors 98 7.6.1 Premdharan Meyyan, Cardiovascular Analyst, Medical Devices 98 7.6.2 Linda Tian, Msc, Managing Analyst, Medical Devices 98 7.6.3 Tyler Fletcher, Global Head of Medical Devices 99 7.7 About GlobalData 100 7.8 Disclaimer 100
List of Tables
Table 1: Medicare National Average of Inpatient Hospital Reimbursement for Percutaneous Coronary Interventions, 2015-2016 15 Table 2: Hospital Outpatient Reimbursement for Percutaneous Coronary Interventions, 2015 16 Table 3: Key Mergers, Acquisitions, and Partnerships in Percutaneous Coronary Interventions Market 23 Table 4: Complex Coronary Indications and Estimated Incidence 24 Table 5: Abbott Vascular - Company SWOT Analysis 34 Table 6: Abbott Vascular - Marketed Products Assessment 35 Table 7: B. Braun - Company SWOT Analysis 38 Table 8: B. Braun - Marketed Products Assessment 39 Table 9: Biosensors International - Company SWOT Analysis 42 Table 10: Biosensors International - Marketed Products Assessment 43 Table 11: Biotronik - Company SWOT Analysis 46 Table 12: Biotronik - Marketed Products Assessment 47 Table 13: Boston Scientific - Company SWOT Analysis 50 Table 14: Boston Scientific - Marketed Products Assessment 51 Table 15: Medtronic - Company SWOT Analysis 53 Table 16: Medtronic - Marketed Products Assessment 54 Table 17: Terumo - Company SWOT Analysis 57 Table 18: Terumo - Marketed Products Assessment 57 Table 19: Other Players Assessment 59 Table 20: Pipeline Products Assessment 61 Table 21: Clinical Trials Assessment 64 Table 22: Global Percutaneous Coronary Interventions Procedures Forecast ($m), 2013-2022 66 Table 23: Global Coronary Stents Market Forecast ($m), 2013-2022 70 Table 24: Global PTCA Balloons Market Forecast ($m), 2013-2022 72 Table 25: Global PTCA DEB Market Forecast ($m), 2013-2022 74 Table 26: Global Coronary Stents Market Forecast ($m), 2013-2022 75 Table 27: North America PCI Market Forecast ($m), 2013-2022 77 Table 28: Europe PCI Market Forecast ($m), 2013-2022 78 Table 29: Asia-Pacific Percutaneous Coronary Interventions Market Forecast ($m), 2013-2022 79 Table 30: South America PCI Market Forecast ($m), 2013-2022 80 Table 31: Middle East & Africa PCI Market Forecast ($m), 2013-2022 81
List of Figures
Figure 1: Proportion of Patients Undergoing Repeat Revascularization, by Revascularization Subtype 31 Figure 2: 10MM Market Shares for Coronary Stents, by Country, 2015 33 Figure 3: Global PCI Procedures Forecast, by Region, 2013-2022 65 Figure 4: Global Coronary Stents Market Forecast ($m), 2013-2022 70 Figure 5: Coronary Stents Market Comparison, by Segment, 2015 and 2022 71 Figure 6: Global PTCA Balloons Market Forecast ($m), 2013-2022 72 Figure 7: PTCA Balloons Market Comparison, by Segment, 2015 and 2022 73 Figure 8: Global PTCA DEB Market Forecast ($m), 2013-2022 74 Figure 9: Global PCI Market Forecast ($m), by Region, 2013-2022 75 Figure 10: North America PCI Market Forecast ($m), by Segment, 2013-2022 76 Figure 11: Europe PCI Market Forecast ($m), by Segment, 2012-2022 78 Figure 12: APAC PCI Market Forecast ($m), by Segment, 2013-2022 79 Figure 13: South America PCI Market Forecast ($m), by Segment, 2013-2022 80 Figure 14: Middle East & Africa PCI Market Forecast ($m), by Segment, 2013-2022 81 Figure 15: Percutaneous Coronary Survey Primary Research Participants, by Country 97
Global commercial drone market size is estimated to reach USD 2,069.6 million by 2022, as per a new research report by Radiant Insights, Inc. Increasing application of these machines in various industry sectors such as military, agriculture and energRead More...
Global thermoplastic polyurethane (TPU) films market size is likely to be valued at USD 724.6 million by 2020; as per a new research report by Radiant Insights, Inc. Increase in lightweight plastics demand in order to achieve vehicle fuel efficiencyRead More...
Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the markeRead More...
Global contact lenses market size is estimated to reach USD 12.5 billion by 2020, according to a new industry report by Radiant Insights, Inc. Growing number of ophthalmic disorder observed in global population especially children is likely to driveRead More...
Global Aerial Work Platform (AWP) truck market is expected to be valued at USD 8,003.7 million by 2022, as per a new research report by Radiant Insights, Inc. Rapid infrastructure growth due to rising real estate investment is expected to drive the iRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.